Medical Director, Dyslipidemia
AstraZeneca - US - Wilmington - DE
Posted Nov 4, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $193K-$290K From the posting source checked Nov 16, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $81,444 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +6.9% - Faster than average
197% above the BLS role benchmark for healthcare aggregate.
Matched to SOC 29-1141 - Healthcare aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered From the posting source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Medical Director, Dyslipidemia US - Wilmington - DE Location: Wilmington, Delaware Hybrid: 3 days a week onsite At AstraZeneca, we work together across global boundaries to make an impact and find answers to challenges. We do this with the utmost integrity even in the most difficult situations because we are committed to doing the right thing. We continuously forge partnerships that help pursue world-class medicines in new ways, combining our people's exceptional skills with those of people from all over the globe. The Medical Director - Dyslipidemia supports the development and execution of US Medical strategy for dyslipidemia and related assets. This role translates disease area and brand priorities into actionable medical execution plans, coordinates cross-functional execution, and helps ensure medical activities are aligned to clinical, scientific, customer, healthcare environment, and business needs. The role requires understanding of the disease area and the evolving US healthcare environment. It also requires inspiring change at scale through coordinated medical strategy, external scientific engagement, and transforming care initiatives. It is a key medical role that reports directly to the Medical Head - Dyslipidemia, within the BioPharmaceuticals Business Unit's US Medical CVRM franchise. What you'll do: Lead the development, delivery, and evolution of disease area and brand medical execution strategies and plans Through partnership and innovative thinking, identify external insights, customer needs, healthcare environment trends and opportunities to transform care that inform medical planning and execution Lead the development and execution of scalable and sustainable transforming care initiatives aligned to disease area and medical
Read the full description at astrazeneca.wd3.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
US Medical Head, Dyslipidemia
AstraZeneca - US - Wilmington - DE
Asset Lead Medical Director - Obesity and Related Conditions
Amgen - United States - Remote
Director, Medical Review
DYNE Therapeutics - Waltham, MA
Director, Medical Affairs
Keros Therapeutics Inc - Lexington, MA (Hybrid)